Recent research conducted by NYU Langone Health and its Perlmutter Cancer Center has shed light on the remarkable adaptability of cancer cells in low-glucose environments. This study is pivotal in understanding how tumors evade the effects of chemotherapies, particularly those classified as
Prostate cancer remains the most common cancer in men, presenting significant challenges for healthcare systems worldwide. The journey for a prostate cancer patient is often fraught with difficult choices and life-altering treatments. However, recent advancements in medical technology and
In a bold move to tackle one of the most formidable cancers, Anocca AB has announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for their innovative VIDAR-1 Phase I/II multi-asset trial, targeting advanced pancreatic cancer. The pioneering trial, set
Recent scientific advancements in cancer research are unveiling the complex behaviors and interactions within tumors through innovative technologies such as 3D tumor mapping and single-cell analysis. These methods allow researchers to delve deeper into the intricacies of tumor development and
The growing disparities in cancer treatment between high- and low-income countries are becoming more pronounced, with significant inequalities in the cost and availability of cancer drugs globally. Predictions indicate that by 2040 the world will witness an estimated 28.4 million new cancer cases
In a significant stride for cancer detection, Mursla Bio recently announced encouraging results from its multi-center clinical study, MEV01, which focuses on the early detection of liver cancer, particularly Hepatocellular Carcinoma (HCC), using their innovative dynamic biopsy technology. Conducted
